13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 58 holding rows worth $1,181,041,000.
- Accession
- 0001172661-21-001824
- Filer
- CIK 1792126
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 58 entries on the cover page, a total value of $1,181,041,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,181,041,000 with VALUE read as thousands by filing date, 13F file number 028-20025. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 3,156,981 | $172,624,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $104,754,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,732,501 | $54,349,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 758,265 | $45,685,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,054,392 | $43,224,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,100,000 | $40,271,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 325,000 | $37,047,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 1,070,762 | $32,905,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 1,696,850 | $32,783,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 850,000 | $32,428,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,002,382 | $31,765,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 400,000 | $31,208,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 1,329,602 | $30,953,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 1,215,000 | $30,241,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,125,000 | $29,273,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 989,095 | $29,020,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,400,000 | $27,706,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,231,812 | $26,275,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 750,000 | $23,843,000 | thousands by filing date | call |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 350,000 | $22,120,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 715,000 | $21,707,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 939,545 | $20,867,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 1,162,320 | $18,144,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 2,500,000 | $15,775,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 724,333 | $15,740,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,410,812 | $14,447,000 | thousands by filing date | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 547,122 | $13,651,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 2,300,000 | $12,489,000 | thousands by filing date | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 780,331 | $12,126,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 675,000 | $11,853,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,420,500 | $11,520,000 | thousands by filing date | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 400,000 | $11,452,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 800,000 | $11,144,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 800,000 | $11,096,000 | thousands by filing date | |
| LANDOS BIOPHARMA INC | 515069102 | CMN | 899,106 | $10,385,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 330,000 | $10,289,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 270,000 | $8,583,000 | thousands by filing date | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 507,923 | $7,461,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 288,458 | $7,428,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 206,564 | $7,056,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 300,000 | $6,810,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 3,190,000 | $6,731,000 | thousands by filing date | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 2,000,000 | $6,600,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 212,785 | $4,339,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 112,928 | $4,273,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 299,853 | $4,210,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 159,622 | $3,593,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 200,000 | $2,276,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 200,000 | $2,144,000 | thousands by filing date | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 224,071 | $1,772,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 125,010 | $1,655,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC COM | 30318F100 | Stock | 123,543 | $1,233,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 100,000 | $1,020,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 100,000 | $1,014,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 37,069 | $844,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 50,000 | $518,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $173,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 46,984 | $149,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-21-001824 | this filing | 2021-08-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001172661-21-001892 | base | 2021-08-17 | acceptance time not in the bulk data set |